SCHEMBL14924747

SCHEMBL14924747

CCOC(=O)C(C(=O)OCC)c1cccn(-c2ccc(C)cc2COC)c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 5/20 0.35
NPSR1 Q6W5P4 2/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
MAPK1 P28482 2/20 0.33
SRC P12931 1/20 0.33
MAPT P10636 2/20 0.33
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LPAR1 Q92633 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
MMP8 P22894 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14924783 0.85 LPAR1 (0.38) KDM4EALDH1A1NPSR1L3MBTL1MAPK1
SCHEMBL14924748 0.77 PTGS2 (0.44) ALDH1A1F2F10SRCMAPT
SCHEMBL14924766 0.77 F2 (0.47) KDM4EALDH1A1F2F10MAPT
SCHEMBL14924764 0.77 F2 (0.34) KDM4EALDH1A1NPSR1F2F10
SCHEMBL16919026 0.69 ALDH1A1 (0.33) KDM4EALDH1A1NPSR1L3MBTL1MAPK1
SCHEMBL12179486 0.68 ALDH1A1 (0.39) KDM4EALDH1A1L3MBTL1MAPTLMNA
SCHEMBL14924778 0.65 PTGS2 (0.42) KDM4EALDH1A1NPSR1L3MBTL1SRC
SCHEMBL3750648 0.64 F2RL3 (0.40) ALDH1A1NPSR1L3MBTL1MAPK1MAPT
SCHEMBL1190584 0.63 CASP1 (0.43) KDM4EL3MBTL1HSD17B10TSHRTDP1
SCHEMBL7513221 0.62 MMP8 (0.50) ALDH1A1NPSR1L3MBTL1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116443-A1 METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116443-A1 METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE PNPO, CYP4B1, DPYD KDM4E 1665/4885ALDH1A1 488/4885NPSR1 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.